Piper Jaffray Reiterates Overweight on NuVasive

Piper Jaffray is out with its report today on NuVasive NUVA, reiterating Overweight. In its report, Piper Jaffray writes, "After reviewing the key lingering issues putting pressure on NUVA we remain bullish on NUVA and recommend that investors buy the stock at current levels." Piper Jaffray maintains a $35 PT on NUVA. At the time of posting, shares of NUVA were trading at $19.35, up 3.53% from Thursday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorReiterationAnalyst RatingsPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!